Optimizing a go-to-market and monetization strategy for a digital mental healthcare provider

China is at the forefront of global cell and gene therapy (CGT) developmentAccording to Nature research in 2021, China accounts for over 50 percent of cell therapy trials worldwide. Today, there are around 400 ongoing CAR-T trials in China across a broad range of targets and diverse indications, from hematology/oncology to solid tumors.Among the frontrunners, Fosun Kite’s Yescarta and JW Therapeut